NanoString And Visiopharm Announce Collaboration To Co-develop Integrated Workflows For GeoMx And AtoMx Spatial Biology Solutions
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and Visiopharm, a world leader in AI-driven digital pathology software, today announced a
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 528 companies set new 52-week lows.
NanoString Technologies Q2 EPS $(0.85) Misses $(0.68) Estimate, Sales $32.22M Miss $32.32M Estimate
NanoString Technologies (NASDAQ:NSTG) reported quarterly losses of $(0.85) per share which missed the analyst consensus estimate of $(0.68) by 25 percent. This is a 41.67 percent decrease over losses of $(0.60) per share
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 120 companies achieved new lows for the year.
NanoString Technologies Earnings Perspective: Return On Capital Employed
Benzinga Pro data, NanoString Technologies (NASDAQ:NSTG) reported Q1 sales of $31.08 million. Earnings fell to a loss of $39.50 million, resulting in a 34.99% decrease from last quarter.
Morgan Stanley Maintains Equal-Weight on NanoString Technologies, Lowers Price Target to $30
Morgan Stanley analyst Tejas Savant maintains NanoString Technologies (NASDAQ:NSTG) with a Equal-Weight and lowers the price target from $45 to $30.
Recap: NanoString Technologies Q1 Earnings
NanoString Technologies (NASDAQ:NSTG) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.